T5	B-Entity	0	6	Tandem	Tandem	B-NP	JJ	O	7	NMOD	O
T5,T6	I-Entity,B-Entity	7	9	AP	AP	I-NP	NN	B-protein	4	NMOD	B-protein
T5,T6	I-Entity,I-Entity	9	10	-	-	B-NP	HYPH	I-protein	4	P	I-protein
T5,T6	I-Entity,I-Entity	10	11	1	1	I-NP	CD	I-protein	1	NMOD	I-protein
T5	I-Entity	11	12	-	-	I-NP	HYPH	B-DNA	7	NMOD	B-DNA
T5	I-Entity	12	19	binding	bind	I-NP	VBG	I-DNA	7	NMOD	I-DNA
T5	I-Entity	20	25	sites	site	I-NP	NNS	I-DNA	0	ROOT	I-DNA
O	O	26	32	within	within	B-PP	IN	O	7	NMOD	O
O	O	33	36	the	the	B-NP	DT	O	17	NMOD	O
O	O	37	42	human	human	I-NP	JJ	B-DNA	17	NMOD	B-DNA
T1	B-Protein	43	47	beta	beta	I-NP	SYM	I-DNA	17	NMOD	I-DNA
T1	I-Protein	47	48	-	-	I-NP	HYPH	I-DNA	17	NMOD	I-DNA
T1	I-Protein	48	54	globin	globin	I-NP	NN	I-DNA	17	NMOD	I-DNA
T7	B-Entity	55	63	dominant	dominant	I-NP	JJ	I-DNA	17	NMOD	I-DNA
T7	I-Entity	64	71	control	control	I-NP	NN	I-DNA	17	NMOD	I-DNA
T7	I-Entity	72	78	region	region	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	79	87	function	function	I-NP	NN	O	8	PMOD	O
O	O	88	90	as	as	B-PP	IN	O	7	NMOD	O
O	O	91	93	an	an	B-NP	DT	O	21	NMOD	O
T8	B-Entity	94	103	inducible	inducible	I-NP	JJ	B-DNA	21	NMOD	B-DNA
T8	I-Entity	104	112	enhancer	enhancer	I-NP	NN	I-DNA	18	PMOD	I-DNA
O	O	113	115	in	in	B-PP	IN	O	7	NMOD	O
O	O	116	125	erythroid	erythroid	B-NP	JJ	B-cell_type	24	NMOD	B-cell_type
O	O	126	131	cells	cell	I-NP	NNS	I-cell_type	22	PMOD	I-cell_type
O	O	131	132	.	.	O	.	O	7	P	O

O	O	134	135	A	A	B-NP	DT	O	3	NMOD	O
O	O	136	144	powerful	powerful	I-NP	JJ	O	3	NMOD	O
T9	B-Entity	145	153	enhancer	enhancer	I-NP	NN	B-DNA	4	SUB	B-DNA
O	O	154	157	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	158	162	been	be	I-VP	VBN	O	4	VC	O
O	O	163	169	mapped	map	I-VP	VBN	O	5	VC	O
O	O	170	172	to	to	B-PP	TO	O	6	VMOD	O
O	O	173	175	an	an	B-NP	DT	O	13	NMOD	O
T10	B-Entity	176	178	18	18	I-NP	CD	B-DNA	13	NMOD	B-DNA
T10	I-Entity	178	179	-	-	I-NP	HYPH	I-DNA	13	NMOD	I-DNA
T10	I-Entity	179	181	bp	bp	I-NP	NN	I-DNA	13	NMOD	I-DNA
T10	I-Entity	182	185	DNA	DNA	I-NP	NN	I-DNA	13	NMOD	I-DNA
T10	I-Entity	186	193	segment	segment	I-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	194	201	located	located	I-NP	JJ	O	13	NMOD	O
O	O	202	204	11	11	I-NP	CD	O	14	AMOD	O
O	O	205	207	kb	kb	I-NP	NN	O	15	PMOD	O
O	O	208	209	5	5	B-NP	CD	O	16	OBJ	O
O	O	209	210	'	'	I-NP	SYM	O	17	NMOD	O
O	O	211	213	to	to	B-PP	TO	O	18	VMOD	O
O	O	214	217	the	the	B-NP	DT	O	25	NMOD	O
O	O	218	223	human	human	I-NP	JJ	B-DNA	25	NMOD	B-DNA
T2	B-Protein	224	231	epsilon	epsilon	I-NP	NN	I-DNA	25	NMOD	I-DNA
T2	I-Protein	231	232	-	-	I-NP	HYPH	I-DNA	25	NMOD	I-DNA
T2	I-Protein	232	238	globin	globin	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	239	243	gene	gene	I-NP	NN	I-DNA	19	PMOD	I-DNA
O	O	244	250	within	within	B-PP	IN	O	25	NMOD	O
O	O	251	254	the	the	B-NP	DT	O	34	NMOD	O
T11	B-Entity	255	263	dominant	dominant	I-NP	JJ	B-DNA	29	NMOD	B-DNA
T11	I-Entity	264	271	control	control	I-NP	NN	I-DNA	34	NMOD	I-DNA
O	O	272	274	or	or	I-NP	CC	I-DNA	34	NMOD	I-DNA
T12	B-Entity	275	280	locus	locus	I-NP	NN	I-DNA	34	NMOD	I-DNA
T12	I-Entity	280	281	-	-	O	HYPH	I-DNA	34	NMOD	I-DNA
T12	I-Entity	281	291	activating	activate	B-VP	VBG	I-DNA	34	NMOD	I-DNA
T12	I-Entity	292	298	region	region	B-NP	NN	I-DNA	26	PMOD	I-DNA
O	O	298	299	.	.	O	.	O	4	P	O

O	O	300	304	This	This	B-NP	DT	O	2	NMOD	O
T13	B-Entity	305	313	enhancer	enhancer	I-NP	NN	B-DNA	3	SUB	B-DNA
O	O	314	316	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	317	326	inducible	inducible	B-ADJP	JJ	O	3	PRD	O
O	O	327	329	in	in	B-PP	IN	O	4	AMOD	O
O	O	330	334	K562	K562	B-NP	NN	B-cell_line	9	NMOD	B-cell_line
O	O	335	340	human	human	I-NP	JJ	I-cell_line	9	NMOD	I-cell_line
O	O	341	356	erythroleukemia	erythroleukemia	I-NP	NN	I-cell_line	9	NMOD	I-cell_line
O	O	357	362	cells	cell	I-NP	NNS	I-cell_line	5	PMOD	I-cell_line
O	O	362	363	,	,	O	,	O	3	P	O
O	O	364	374	increasing	increase	B-VP	VBG	O	3	VMOD	O
O	O	375	381	linked	link	B-NP	VBN	O	20	NMOD	O
T3	B-Protein	382	387	gamma	gamma	I-NP	SYM	O	20	NMOD	O
T3	I-Protein	387	388	-	-	I-NP	HYPH	O	20	NMOD	O
T3	I-Protein	388	394	globin	globin	I-NP	NN	B-DNA	16	NMOD	B-DNA
T14	B-Entity	395	403	promoter	promoter	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	403	404	/	/	B-NP	SYM	O	20	NMOD	O
T4	B-Protein	404	414	luciferase	luciferase	I-NP	NN	B-DNA	20	NMOD	B-DNA
O	O	415	419	gene	gene	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	420	430	expression	expression	I-NP	NN	O	11	OBJ	O
O	O	431	433	to	to	B-PP	TO	O	11	VMOD	O
O	O	434	437	170	170	B-NP	CD	O	21	PMOD	O
O	O	437	438	-	-	O	HYPH	O	22	P	O
O	O	438	442	fold	fold	B-ADVP	RB	O	22	NMOD	O
O	O	443	447	over	over	B-PP	IN	O	11	VMOD	O
O	O	448	450	an	an	B-NP	DT	O	28	NMOD	O
O	O	451	463	enhancerless	enhancerless	I-NP	JJ	B-DNA	28	NMOD	B-DNA
O	O	464	473	construct	construct	I-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	473	474	.	.	O	.	O	3	P	O

O	O	475	478	The	The	B-NP	DT	O	2	NMOD	O
T15	B-Entity	479	487	enhancer	enhancer	I-NP	NN	B-DNA	3	SUB	B-DNA
O	O	488	496	consists	consist	B-VP	VBZ	O	0	ROOT	O
O	O	497	499	of	of	B-PP	IN	O	3	VMOD	O
T16	B-Entity	500	506	tandem	tandem	B-NP	JJ	B-DNA	11	NMOD	B-DNA
T16,T17	I-Entity,B-Entity	507	509	AP	AP	I-NP	NN	I-DNA	11	NMOD	I-DNA
T16,T17	I-Entity,I-Entity	509	510	-	-	B-NP	HYPH	I-DNA	8	P	I-DNA
T16,T17	I-Entity,I-Entity	510	511	1	1	I-NP	CD	I-DNA	11	NMOD	I-DNA
T16	I-Entity	511	512	-	-	O	HYPH	I-DNA	11	NMOD	I-DNA
T16	I-Entity	512	519	binding	bind	B-NP	VBG	I-DNA	11	NMOD	I-DNA
T16	I-Entity	520	525	sites	site	I-NP	NNS	I-DNA	4	PMOD	I-DNA
O	O	525	526	,	,	O	,	O	11	P	O
O	O	527	533	phased	phase	B-VP	VBD	O	16	AMOD	O
T18	B-Entity	534	536	10	10	B-NP	CD	O	15	NMOD	O
T18	I-Entity	537	539	bp	bp	I-NP	NN	O	16	AMOD	O
O	O	540	545	apart	apart	B-ADVP	RB	O	11	NMOD	O
O	O	545	546	,	,	O	,	O	11	P	O
O	O	547	552	which	which	B-NP	WDT	O	11	NMOD	O
O	O	553	556	are	be	B-VP	VBP	O	18	SBAR	O
O	O	557	561	both	both	O	DT	O	19	VMOD	O
O	O	562	570	required	require	B-VP	VBN	O	19	VC	O
O	O	571	574	for	for	B-PP	IN	O	21	VMOD	O
O	O	575	579	full	full	B-NP	JJ	O	24	NMOD	O
O	O	580	588	activity	activity	I-NP	NN	O	22	PMOD	O
O	O	588	589	.	.	O	.	O	3	P	O

O	O	590	593	DNA	DNA	B-NP	NN	O	5	NMOD	O
O	O	593	594	-	-	I-NP	HYPH	O	5	NMOD	O
O	O	594	601	protein	protein	I-NP	NN	O	5	NMOD	O
O	O	602	609	binding	binding	I-NP	NN	O	5	NMOD	O
O	O	610	616	assays	assay	I-NP	NNS	O	12	SUB	O
O	O	617	621	with	with	B-PP	IN	O	5	NMOD	O
O	O	622	629	nuclear	nuclear	B-NP	JJ	O	8	NMOD	O
O	O	630	638	extracts	extract	I-NP	NNS	O	6	PMOD	O
O	O	639	643	from	from	B-PP	IN	O	8	NMOD	O
O	O	644	651	induced	induce	B-NP	VBN	O	11	NMOD	O
O	O	652	657	cells	cell	I-NP	NNS	O	9	PMOD	O
O	O	658	669	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	670	671	a	a	B-NP	DT	O	17	NMOD	O
T19	B-Entity	672	676	high	high	I-NP	JJ	B-protein	17	NMOD	B-protein
T19	I-Entity	677	686	molecular	molecular	I-NP	JJ	I-protein	17	NMOD	I-protein
T19	I-Entity	687	693	weight	weight	I-NP	NN	I-protein	17	NMOD	I-protein
T19	I-Entity	694	701	complex	complex	I-NP	NN	I-protein	12	OBJ	I-protein
O	O	702	704	on	on	B-PP	IN	O	17	NMOD	O
O	O	705	708	the	the	B-NP	DT	O	20	NMOD	O
T20	B-Entity	709	717	enhancer	enhancer	I-NP	NN	B-DNA	18	PMOD	B-DNA
O	O	717	718	.	.	O	.	O	12	P	O

O	O	719	722	The	The	B-NP	DT	O	2	NMOD	O
O	O	723	732	formation	formation	I-NP	NN	O	7	SUB	O
O	O	733	735	of	of	B-PP	IN	O	2	NMOD	O
O	O	736	740	this	this	B-NP	DT	O	5	NMOD	O
O	O	741	748	complex	complex	I-NP	NN	O	3	PMOD	O
O	O	749	753	also	also	B-ADVP	RB	O	7	VMOD	O
O	O	754	762	requires	require	B-VP	VBZ	O	0	ROOT	O
O	O	763	767	both	both	O	CC	O	12	NMOD	O
T21,T22	B-Entity,B-Entity	768	770	AP	AP	B-NP	NN	B-DNA	12	NMOD	B-DNA
T21,T22	I-Entity,I-Entity	770	771	-	-	O	HYPH	I-DNA	12	NMOD	I-DNA
T21,T22	I-Entity,I-Entity	771	772	1	1	B-NP	CD	I-DNA	12	NMOD	I-DNA
T21	I-Entity	773	778	sites	site	I-NP	NNS	I-DNA	7	OBJ	I-DNA
O	O	779	782	and	and	O	CC	O	7	VMOD	O
O	O	783	793	correlates	correlate	B-VP	VBZ	O	7	VMOD	O
O	O	794	798	with	with	B-PP	IN	O	14	VMOD	O
O	O	799	806	maximal	maximal	B-NP	JJ	O	18	NMOD	O
T23	B-Entity	807	815	enhancer	enhancer	I-NP	NN	O	18	NMOD	O
O	O	816	824	activity	activity	I-NP	NN	O	15	PMOD	O
O	O	824	825	.	.	O	.	O	7	P	O

O	O	826	835	Induction	Induction	B-NP	NN	O	5	SUB	O
O	O	836	838	of	of	B-PP	IN	O	1	NMOD	O
O	O	839	842	the	the	B-NP	DT	O	4	NMOD	O
T24	B-Entity	843	851	enhancer	enhancer	I-NP	NN	B-DNA	2	PMOD	B-DNA
O	O	852	855	may	may	B-VP	MD	O	0	ROOT	O
O	O	856	860	have	have	I-VP	VB	O	5	VC	O
O	O	861	862	a	a	B-NP	DT	O	8	NMOD	O
O	O	863	867	role	role	I-NP	NN	O	6	OBJ	O
O	O	868	870	in	in	B-PP	IN	O	6	VMOD	O
O	O	871	874	the	the	B-NP	DT	O	11	NMOD	O
O	O	875	883	increase	increase	I-NP	NN	O	9	PMOD	O
O	O	884	886	in	in	B-PP	IN	O	11	NMOD	O
T25	B-Entity	887	893	globin	globin	B-NP	NN	B-DNA	14	NMOD	B-DNA
T25	I-Entity	894	898	gene	gene	I-NP	NN	I-DNA	15	NMOD	I-DNA
O	O	899	912	transcription	transcription	I-NP	NN	O	12	PMOD	O
O	O	913	917	that	that	B-NP	WDT	O	15	NMOD	O
O	O	918	931	characterizes	characterize	B-VP	VBZ	O	16	SBAR	O
O	O	932	941	erythroid	erythroid	B-NP	JJ	O	19	NMOD	O
O	O	942	952	maturation	maturation	I-NP	NN	O	17	OBJ	O
O	O	952	953	.	.	O	.	O	5	P	O

T26	B-Entity	954	962	Enhancer	Enhancer	B-NP	NN	O	2	NMOD	O
O	O	963	971	activity	activity	I-NP	NN	O	3	SUB	O
O	O	972	979	appears	appear	B-VP	VBZ	O	0	ROOT	O
O	O	980	982	to	to	I-VP	TO	O	5	VMOD	O
O	O	983	985	be	be	I-VP	VB	O	3	VMOD	O
O	O	986	994	mediated	mediate	I-VP	VBN	O	5	VC	O
O	O	995	997	by	by	B-PP	IN	O	6	VMOD	O
O	O	998	1001	the	the	B-NP	DT	O	9	NMOD	O
O	O	1002	1009	binding	binding	I-NP	NN	O	7	PMOD	O
O	O	1010	1012	of	of	B-PP	IN	O	9	NMOD	O
O	O	1013	1014	a	a	B-NP	DT	O	12	NMOD	O
T27	B-Entity	1015	1022	complex	complex	I-NP	NN	O	10	PMOD	O
O	O	1023	1025	of	of	B-PP	IN	O	12	NMOD	O
O	O	1026	1034	proteins	protein	B-NP	NNS	O	13	PMOD	O
O	O	1035	1039	from	from	B-PP	IN	O	14	NMOD	O
O	O	1040	1043	the	the	B-NP	DT	O	20	NMOD	O
O	O	1044	1047	jun	jun	I-NP	NN	B-DNA	20	NMOD	B-DNA
O	O	1048	1051	and	and	I-NP	CC	I-DNA	20	NMOD	I-DNA
O	O	1052	1055	fos	fos	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	1056	1064	families	family	I-NP	NNS	I-DNA	15	PMOD	I-DNA
O	O	1065	1067	to	to	B-PP	TO	O	9	NMOD	O
T28	B-Entity	1068	1074	tandem	tandem	B-NP	JJ	B-DNA	27	NMOD	B-DNA
T28,T29	I-Entity,B-Entity	1075	1077	AP	AP	I-NP	NN	I-DNA	27	NMOD	I-DNA
T28,T29	I-Entity,I-Entity	1077	1078	-	-	B-NP	HYPH	I-DNA	27	P	I-DNA
T28,T29	I-Entity,I-Entity	1078	1079	1	1	I-NP	CD	I-DNA	27	NMOD	I-DNA
T28	I-Entity	1080	1089	consensus	consensus	I-NP	NN	I-DNA	27	NMOD	I-DNA
T28	I-Entity	1090	1099	sequences	sequence	I-NP	NNS	I-DNA	21	PMOD	I-DNA
O	O	1099	1100	.	.	O	.	O	3	P	O
